PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII) today reported financial results for the three and nine months ended September 30, 2007. “We are making tangible progress against well-defined programs that we believe hold significant near-term commercialization potential,” said K. Michael Forrest, interim chief executive officer of AVI. Key achievements during the first nine months of 2007 include:
